These findings collectively uncover a paradigm wherein tumor-resident microbiota epigenetically recalibrates cancer cell plasticity through NOD1-NUMB-NOTCH1 signaling, thereby redefining microbial-host interactions as critical modulators of therapeutic responsiveness in breast cancer (Ma et al., 2024). This evidence concerns the gene NOD1 and breast cancer.